Board Meeting28 Jul 2026, 10:51 am
Krebs Biochemicals Board Meeting on Aug 6 to Approve Q1 Unaudited Results
AI Summary
Krebs Biochemicals & Industries Ltd has announced that its Board of Directors will convene on August 6, 2026. The primary agenda item is to consider and approve the unaudited financial results for the first quarter ended June 30, 2026. Concurrently, the company reaffirmed its trading window closure for insiders, which began on June 30, 2026, and will remain shut until 48 hours post the declaration of these financial results, as per SEBI regulations.
Key Highlights
- Board meeting scheduled for August 6, 2026.
- Agenda includes approval of Q1 FY27 unaudited financial results.
- Trading window for insiders remains closed until results announcement.
- Compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Price Impact
More from KREBSBIO